powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1033555164
Jeong-Hee Ku
M.D.
Endocrinology
Los Angeles,
CA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (4)
CCN 050112
Hospital
CCN 050235
Hospital
CCN 050262
Hospital
CCN 050481
Hospital
QUALITY · MIPS · 2024
Final MIPS score
87.5
Quality
79.4
Cost
73.7
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.53%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$195
Payment records
6
By payment type
Food and Beverage
$195
PRESCRIBING · PART D · 2024
Total Rx claims
5,019
Beneficiaries
—
Total drug cost
$2.8M
Distinct drugs
60
Brand share
59.5%
Top prescribed drugs
Semaglutide
482 claims
Levothyroxine Sodium
432 claims
Tirzepatide
305 claims
Metformin Hcl
267 claims
Metformin Hcl
262 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
642
Unique beneficiaries
—
Total services
2,055
Distinct HCPCS
12
Medicare payment
$98K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 633 Endocrinology providers in CA — top quintile (cohort median 1,164).
